Hybio Pharmaceutical Co., Ltd.

Chinese peptide drug maker, API supplier and CRDMO service provider

What Hybio Pharmaceutical does

Hybio is a Wuhan-based drugmaker, founded in 1998, that specializes in peptides, which are short chains of amino acids used as medicines. It makes finished drugs for areas such as women's health, bleeding control, diabetes, heart disease and osteoporosis, plus disposable injection pens. It also produces raw drug ingredients and makes drugs under contract for other pharmaceutical companies.

How Hybio Pharmaceutical makes money

It earns most of its revenue by selling finished drugs and peptide APIs to customers in China and abroad, and by charging fees for contract research, development and manufacturing of peptides and oligonucleotides. Smaller income comes from technical services, property services and leasing out non-residential real estate.

Products & services

• Peptide finished dosage form drugs
• Peptide APIs (polypeptides, small molecules, nucleic acids)
• Pharmaceutical intermediates
• Disposable injectable pens
• Peptide and oligonucleotide CRDMO services